Next Article in Journal
Evaluation of Small Molecular Polypeptides from the Mantle of Pinctada Martensii on Promoting Skin Wound Healing in Mice
Next Article in Special Issue
First Synthesis of (−)-Altenuene-D3 Suitable as Internal Standard for Isotope Dilution Mass Spectrometry
Previous Article in Journal
Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application
Previous Article in Special Issue
Some Biogenetic Considerations Regarding the Marine Natural Product (−)-Mucosin
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Total Synthesis of the Proposed Structure of Paraphaeosphaeride C †

Graduate School of Pharmaceutical Sciences, Meiji Pharmaceutical University, Tokyo 204-8588, Japan
*
Authors to whom correspondence should be addressed.
Dedicated to Professor Dieter Schinzer on the occasion of his 65th birthday.
Molecules 2019, 24(23), 4230; https://doi.org/10.3390/molecules24234230
Submission received: 30 October 2019 / Revised: 15 November 2019 / Accepted: 19 November 2019 / Published: 21 November 2019

Abstract

:
Paraphaeosphaeride C is a demethoxy derivative of phaeosphaeride A and exhibits STAT3 inhibitory activity. Our previous papers reported the total synthesis of phaeosphaeride A using a diastereoselective vinyl anion aldol reaction as the key step to construct the dihydropyran ring. In this work, the first total synthesis of the proposed structure of paraphaeosphaeride C was achieved via a similar synthetic strategy. The synthetic compound was characterized through extensive nuclear magnetic resonance (NMR) analysis but the 1H and 13C-NMR data for this compound did not correspond to those reported in the literature for paraphaeosphaeride C.

1. Introduction

Paraphaeosphaerides A–C (13, Figure 1) were isolated from Paraphaeosphaeria neglecta FT462 by Cao and co-workers in 2015 [1] and these natural products are structurally related to phaeosphaerides A (4) and B (5) [2]. Among them, paraphaeosphaeride C (PPPC, 3), which is a demethoxy derivative of phaeosphaeride A (4), was reported to exhibit STAT3 inhibitory activity at 10 μM against MDA-MB-231 breast cancer cells. In addition, 3 was reported to be active against A2780 and A2780cisR (cisplatin-resistant A2780) cells with IC50 values of 15.0 and 52.4 μM, respectively. Thus, 3 might be a potential lead compound for anti-cancer drug discovery alongside phaeosphaeride A [3,4,5,6,7,8].
In our previous work, we achieved the total synthesis of phaeosphaerides A (4) and B (5), using a diastereoselective vinyl anion aldol reaction of aldehyde 6 to form 7 as the key step for assembling the dihydropyran core (Scheme 1) [9,10,11].
We envisaged that a similar synthetic strategy could be applied to the synthesis of paraphaeosphaeride C (3) from the same intermediate 7. This paper describes the first total synthesis of the proposed structure of paraphaeosphaeride C (3).

2. Results and Discussion

Our synthesis commenced with the preparation of the key synthetic intermediate 7 used to obtain phaeosphaerides A and B (Scheme 2). According to our previously reported protocol [11], n-hexanal was converted over 10 steps into aldehyde 6, which was then subjected to the vinyl anion aldol reaction using sodium bis(trimethylsilyl)amide (NaHMDS) in THF. In our previous work, dihydropyran derivative 7 was obtained in 56% yield but the reaction unexpectedly suffered from low yield and lack of reproducibility. Several batches of NaHMDS and THF from different lots and suppliers were screened; nevertheless, the yield of product 7 did not improve. Thus, re-examination of this reaction was required.
We initially attempted to use lithium tetramethylpiperidide (LiTMP) prepared from tetramethylpiperidine (TMP) and n-BuLi in situ (Table 1). When TMP (1.5 equiv) and n-BuLi (1.5 equiv) were used, the desired product 7 and its diastereomer 8 were obtained in 21% and 8% yield, respectively, along with recovery of the starting aldehyde 6 in 40% yield (entry 1). Upon doubling the amount of each reagent, the yield of 7 improved to 42% but remained unsatisfactory (entry 2). Further increasing the amounts of TMP and n-BuLi apparently diminished the combined yield of the products, albeit with no recovery of aldehyde 6 (entry 3). To our delight, use of the Knochel-Hauser base TMPMgCl·LiCl (3 equiv) [12,13,14] afforded 7 in 82% yield and significantly improved stereoselectivity (entry 4). Furthermore, this reagent reproducibly delivered the desired product 7 in high yield. In this reaction, we suppose that the strong basicity of TMPMgCl·LiCl is crucial and the divalent magnesium ion might stabilize the transition state leading to 7 (Figure 2), because monovalent metal cations (Li, Na and K) resulted in low yield and poor stereoselectivity in our initial experiments [9].
With suitable reaction conditions for the vinyl anion aldol reaction in hand, our attention next turned to further functional group transformations toward the synthesis of PPPC (3) (Scheme 3 and Scheme 4). Following our previously reported method [9,10,11], diester 7 was regioselectively hydrolyzed using aqueous NaOH to afford monoacid 9, which was immediately reacted with ammonia to form amide 10 along with imide 11 in 42% and 46% yield, respectively. Upon heating 10 with Et3N in DMF at 70 °C, imide 11 was efficiently obtained in 80% yield (Scheme 3).
Having synthesized bicyclic compound 11, the remaining task for the total synthesis was achieving regioselective exo-methylenation. Thus, 11 was treated with MeMgBr according to the literature [9,10,11], although only unreacted 11 was recovered. The use of more reactive MeLi also resulted in no reaction. Then, the imide nitrogen in 11 was initially protected with a Boc group to obtain 12 in 82% yield. Subsequent reaction of 12 with MeLi in THF proceeded successfully to furnish hemiaminal 13 in moderate yield (59%), although MeMgBr remained ineffective (Scheme 4).
For dehydration of the hemiaminal moiety and removal of both the Boc and MOM protecting groups to directly convert 13 to PPPC, treatment of 13 with an acid (HCl/1,4-dioxane [9,10,11] or p-TsOH/toluene [3,4]) resulted in complex mixtures of products. However, upon using trifluoroacetic acid (TFA), dehydration and deprotection occurred smoothly to produce a trifluoroacetylated product, which was hydrolyzed with aqueous NaHCO3 to afford diol 14 in 52% yield from 13, the nuclear magnetic resonance (NMR) spectra of which were not consistent with the literature data for PPPC. Diol 14 may be the C-6 epimer of PPPC formed via stereoinversion at C-6, as observed in the synthesis of phaeosphaeride B (5) [11]. The configuration at C-6 in 14 was established using NOESY correlations between H-6 and H-9 and between H-6 and H-15.
To avoid similar stereoinversion at C-6, alcohol 13 was protected via oxidation with Dess-Martin periodinane to afford ketone 15 (94%), which underwent the expected conversion to alcohol 16 upon treatment with TFA. Owing to its instability, 16 was used in the next step without purification. Finally, stereoselective reduction of 16 was accomplished using NaBH(OAc)3 to afford the desired diol 17 in 56% yield from 15, whereas attempted reduction with LiAlH4, DIBAL-H or NaBH4/CeCl3 provided complex mixtures of products.
The gross structure of synthetic 17 was deduced to be the proposed structure PPPC (3) via extensive NMR studies including HMBC and NOESY experiments, as summarized in Figure 3. NOESY correlations suggested a syn relationship between H-6 and H-8, with a flexible conformation of the dihydropyran ring. However, the 1H and 13C-NMR spectra of 17 did not match those reported in the literature for PPPC [1]. Upon comparing the 13C-NMR spectra of 3 and 17, slight differences were observed in the upper five-membered ring, whereas the signals originating from the lower dihydropyran ring were in almost complete agreement (see Supplementary Materials). In addition, the optical rotation of synthetic 17 ( [ α ] D 25 + 38.6 (c 0.08, MeOH)) was not identical to that of the reported natural product 3 ( [ α ] D 25 − 128.6 (c 0.14, MeOH)). These results suggest that PPPC may have a five-membered ring different from that reported in the literature connected to the dihydropyran moiety, although the true structure of PPPC remains uncertain.
In conclusion, we have achieved the first total synthesis of the proposed structure of paraphaeosphaeride C. This synthesis featured a TMPMgCl·LiCl-mediated vinyl anion aldol reaction and subsequent appropriate functional group transformations, including regioselective methylenation and stereoselective reduction to establish the C-6 stereocenter. In addition, this work implies that the structure of natural paraphaeosphaeride C was incorrectly assigned. Further studies toward the structural assignment of the natural product are currently underway in our group.

3. Materials and Methods

3.1. General Experimental Methods

1H-NMR spectra were recorded on a JEOL JNM-AL300 (300 MHz), JEOL JNM-ECS400 (400 MHz) or JEOL JNM-ECA500 (500 MHz) (JEOL Ltd., Akishima, Japan) instrument. The chemical shifts are expressed in ppm relative to tetramethylsilane (δ = 0) as an internal standard (CDCl3 or CD3OD solution). Splitting patterns are indicated as follows—s, singlet; d, doublet; t, triplet; m, multiplet; br, broad peak. 13C-NMR spectra were recorded on a JEOL JNM-ECA500 (125 MHz) or JEOL JNM-ECS400 (100 MHz) instrument. The chemical shifts are reported in ppm relative to the central line of the triplet at 77.0 ppm for CDCl3 or that of the septet at 49.3 ppm for CD3OD. Infrared (IR) spectra were measured on a JASCO VALOR-III spectrometer (JASCO Corporation, Hachioji, Japan) and are reported in wavenumbers (cm−1). Both low-resolution mass spectra (MS) and high-resolution mass spectra (HRMS) were obtained using a JEOL JMS 700 (FAB mode) instrument with a direct inlet system. Optical rotations were measured on a JASCO P-2200 polarimeter using a cell with an optical path length of 100 mm. Column chromatography was performed on silica gel (40–100 mesh, FUJI SILYSIA CHEMICAL Ltd., Kasugai, Japan). Analytical thin-layer chromatography (TLC) was conducted using 0.25 mm silica gel 60 F plates.

3.2. Experimental Procedures and Characterization Data

3.2.1. Dimethyl (2S,3R,4S)-4-Hydroxy-3-Methoxymethoxy-3-Methyl-2-Pentyl-3,4-Dihydro-2H-Pyran-5,6-Dicarboxylate (7)

To a stirred solution of 2,2,6,6-tetramethylpiperidinylmagnesium chloride-lithium chloride complex (1.0 M solution in THF/toluene, 2.3 mL, 2.3 mmol) in THF (8 mL) was added a solution of 6 (269 mg, 0.746 mmol) in THF (6 mL) at −78 °C and the mixture was stirred at the same temperature for 20 min. Saturated aqueous NH4Cl and H2O were then added to the reaction mixture. The resulting mixture was extracted with Et2O and the combined organic layers were dried over Na2SO4 and concentrated in vacuo. The crude product was purified by column chromatography on silica gel (n-hexane/EtOAc 3:1→7:3) to afford 7 (219 mg, 82%) and 8 (26.1 mg, 9%) as colorless oils. The spectral data for 7 and 8 were identical to those reported in the literature [11].

3.2.2. Methyl (2S,3R,4S)-6-Carbamoyl-4-Hydroxy-3-Methoxymethoxy-3-Methyl-2-Pentyl-3,4-Dihydro-2H-Pyran-5-Carboxylate (10) and (2S,3R,4S)-4-Hydroxy-3-Methoxymethoxy-3-Methyl-2-Pentyl-3,4-Dihydropyrano[2,3-c]pyrrole-5,7(2H,6H)-Dione (11)

To a stirred solution of 7 (169 mg, 0.469 mmol) in MeOH (6 mL) was added 1 M aqueous NaOH (0.9 mL, 0.9 mmol) at room temperature. The resulting mixture was stirred at 35 °C for 15 h and then concentrated in vacuo. The residual oil was dissolved in H2O and 1 M aqueous HCl was added to this solution. The mixture was extracted with EtOAc and the combined organic layers were dried over Na2SO4 and concentrated in vacuo. The crude monoacid 9 was used in the next step without further purification. The crude product was dissolved in CH2Cl2 (16 mL) and NH3 (7 N solution in MeOH, 0.10 mL, 0.70 mmol), Et3N (0.15 mL, 1.1 mmol), HOBt∙H2O (90 mg, 0.59 mmol) and EDCI∙HCl (107 mg, 0.56 mmol) were added to this solution at room temperature. The mixture was stirred for 18 h. After addition of H2O, the layers were separated and the aqueous layer was extracted with CH2Cl2. The combined organic layers were dried over Na2SO4 and concentrated in vacuo. The crude product was purified by column chromatography on silica gel (n-hexane/EtOAc 3:2→1:1→3:7→1:4) to afford 10 (67.3 mg, 42%) and 11 (67.1 mg, 46%) as colorless oils.
Conversion of 10 to 11—A solution of 10 (58.7 mg, 0.17 mmol) and Et3N (0.24 mL, 1.7 mmol) in DMF (1.7 mL) was stirred at 70 °C for 7 h. After concentration, the crude product was purified by column chromatography on silica gel (n-hexane/EtOAc 3:2) to afford 11 (42.4 mg, 80%) as a colorless oil.
Spectral data for 10: [ α ] D 24 + 215.4 (c 0.23, CHCl3); IR (neat/NaCl) 3335, 2958, 1686, 1654, 1436, 1261, 1029, 799 cm−1; 1H-NMR (300 MHz, CDCl3) δ 6.25 (br s, 1H), 6.05 (br s, 1H), 4.97 (d, J = 7.6 Hz, 1H), 4.64 (d, J = 8.0 Hz, 1H), 4.59 (d, J = 3.2 Hz, 1H), 4.20 (d, J = 4.0 Hz, 1H), 3.87 (dd, J = 1.6, 10.0 Hz, 1H), 3.81 (s, 3H), 3.43 (s, 3H), 1.90–1.77 (m, 2H), 1.65–1.47 (m, 2H), 1.42–1.25 (m, 5H), 1.22 (s, 3H), 0.91 (t, J = 6.8 Hz, 3H); 13C-NMR (100 MHz, CDCl3) δ 167.4, 162.7, 144.3, 114.9, 91.1, 81.7, 75.7, 72.1, 56.0, 52.5, 31.6, 27.2, 26.1, 22.5, 14.0, 9.8; MS (FAB+) m/z: 346 [M + H]+; HRMS (FAB+) m/z: [M + H]+ Calcd for C16H28NO7 346.1866; Found 346.1864.
Spectral data for 11: [ α ] D 20 − 60.3 (c 0.067, CHCl3); IR (neat/NaCl) 3450, 3266, 2926, 1730, 1672, 1031, 801 cm−1; 1H-NMR (400 MHz, CDCl3) δ 6.93 (br s, 1H), 4.97 (d, J = 8.0 Hz, 1H), 4.67 (d, J = 8.0 Hz, 1H), 4,63 (br s, 1H), 4,11 (br d, J = 8.0 Hz, 1H), 3.45 (s, 3H), 1.87–1.82 (m, 1H), 1.77–1.65 (m, 2H), 1.43–1.28 (m, 6H), 1.25 (s, 3H), 0.90 (t, J = 7.0 Hz, 3H); 13C-NMR (125 MHz, CDCl3) δ 167.4, 163.4, 155.4, 112.4, 91.2, 85.9, 77.2, 69.0, 56.2, 31.6, 27.7, 26.0, 22.5, 14.0, 10.3; MS (FAB+) m/z: 314 [M + H]+; HRMS (FAB+) m/z: [M + H]+ Calcd for C15H24NO6 314.1604; Found 314.1611.

3.2.3. Tert-Butyl (2S,3R,4S)-4-Hydroxy-3-Methoxymethoxy-3-Methyl-5,7-Dioxo-2-Pentyl-3,4,5,7-Tetrahydropyrano[2,3-c]pyrrole-6(2H)-Carboxylate (12)

To a stirred solution of 11 (48.2 mg, 0.154 mmol) in CH3CN (2.5 mL) were added DMAP (1.8 mg, 0.015 mmol) and di-tert-butyl dicarbonate (42.0 mg, 0.192 mmol) at room temperature. After stirring for 2 h, the reaction mixture was concentrated in vacuo. The crude product was purified by column chromatography on silica gel (n-hexane/EtOAc 3:1) to afford 12 (50.6 mg, 82%) as a colorless oil.
Spectral data for 12: [ α ] D 24 − 84.2 (c 0.10, CHCl3); IR (neat/NaCl) 3516, 2958, 1769, 1680, 1258, 1094, 1027, 801 cm−1; 1H-NMR (400 MHz, CDCl3) δ 4.92 (d, J = 7.5 Hz, 1H), 4.70 (d, J = 7.5 Hz, 1H), 4.59 (br s, 1H), 4.25–4.05 (m, 1H), 3.42 (s, 3H), 1.82–1.72 (m, 1H), 1.69–1.58 (m, 1H), 1.57 (s, 9H), 1.41–1.21 (m, 7H), 1.28 (s, 3H), 0.90 (t, J = 7.0 Hz, 3H); 13C-NMR (125 MHz, CDCl3) δ 166.2, 163.8, 154.7, 145.9, 112.8, 91.3, 86.2, 85.0, 77.2, 76.8, 56.1, 31.5, 27.9 (3C), 27.7, 26.1, 22.5, 14.0, 10.1; MS (FAB+) m/z: 414 [M + H]+; HRMS (FAB+) m/z: [M + H]+ Calcd for C20H32NO8 414.2128; Found 414.2134.

3.2.4. Tert-Butyl (2S,3R,4S)-4,7-Dihydroxy-3-Methoxymethoxy-3,7-Dimethyl-5-Oxo-2-Pentyl-3,4,5,7-Tetrahydropyrano[2,3-c]pyrrole-6(2H)-Carboxylate (13)

To a stirred solution of 12 (8.7 mg, 0.021 mmol) in THF (2 mL) was added MeLi (1.16 mmol/mL solution in Et2O, 0.050 mL, 0.06 mmol) at −78 °C. The resulting mixture was stirred at the same temperature for 20 min. The reaction was quenched with saturated aqueous NaHCO3 and the mixture was extracted with CH2Cl2. The combined organic layers were dried over Na2SO4 and concentrated in vacuo. The crude product was purified by column chromatography on silica gel (n-hexane/EtOAc 3:2) to afford 13 (5.1 mg, 59%, 1:1 inseparable mixture) as a colorless oil.
IR (neat/NaCl) 3412, 2927, 1759, 1688, 1330, 1151, 1033, 752 cm−1; 1H-NMR (500 MHz, CDCl3) δ 4.87 (d, J = 7.5 Hz, 1H × 1/2), 4.86 (d, J = 7.5 Hz, 1H × 1/2), 4.82 (d, J = 7.0 Hz, 1H × 1/2), 4.79 (d, J = 7.5 Hz, 1H × 1/2), 4.56 (br s, 1H × 1/2), 4.52 (br s, 1H × 1/2), 4.43 (br s, 1H × 1/2), 4.40 (s, 1H × 1/2), 4.22–4.08 (m, 1H × 1/2), 4.18–4.00 (m, 1H × 1/2), 3.39 (s, 3H), 1.80 (s, 3H), 1.70–1.19 (m, 8H), 1.57 (s, 9H), 1.33 (s, 3H × 1/2), 1.29 (s, 3H × 1/2), 0.90 (t, J = 7.0 Hz, 3H); 13C-NMR (125 MHz, CDCl3) δ 169.9 (both isomers), 150.7 (both isomers), 150.6 (both isomers), 105.0, 104.9, 91.6 (both isomers), 86.1, 85.9, 85.3 (both isomers), 83.8, 83.7, 83.1 (both isomers), 76.5 (both isomers), 56.0, 55.9, 31.62, 31.57, 28.2 (3C, both isomers), 27.94, 27.90, 26.19, 26.17, 23.5, 23.4, 22.55, 22.49, 14.0 (2C, both isomers); MS (FAB+) m/z: 430 [M + H]+; HRMS (FAB+) m/z: [M + H]+ Calcd for C21H36NO8 430.2441; Found 430.2448.

3.2.5. (2S,3R,4R)-3,4-Dihydroxy-3-Methyl-7-Methylene-2-Pentyl-3,4,6,7-Tetrahydropyrano[2,3-c]pyrrol-5(2H)-One (14)

Compound 13 (3.3 mg, 0.0077 mmol) was dissolved in TFA (0.3 mL) and the resulting mixture was stirred for 1 h at room temperature. After concentration under vacuum, the crude product was dissolved in THF (0.4 mL). To this solution was added half-saturated aqueous NaHCO3 (0.2 mL). The reaction mixture was stirred for 2 h at room temperature and then diluted with saturated aqueous NaCl. The mixture was extracted with Et2O and the combined organic layers were dried over Na2SO4 and concentrated in vacuo. The crude product was purified by column chromatography on silica gel (n-hexane/EtOAc 3:7) to afford 14 (1.1 mg, 52%) as a colorless oil.
[ α ] D 25 + 15.3 (c 0.06, MeOH); IR (neat/NaCl) 3303, 3231, 2954, 2927, 2372, 2311, 1698, 1637, 1056, 918 cm−1; 1H-NMR (500 MHz, CD3OD) δ 4.97 (d, J = 1.0 Hz, 1H), 4.87 (d, J = 1.5 Hz, 1H), 4.04 (dd, J = 2.0, 10.5 Hz, 1H), 3.96 (s, 1H), 1.98–1.90 (m, 1H), 1.74–1.58 (m, 2H), 1.52–1.25 (m, 5H), 1.00 (s, 3H), 0.94 (t, J = 7.5 Hz, 3H); 13C-NMR (125 MHz, CD3OD) δ 172.3, 160.3, 139.3, 108.4, 93.8, 82.1, 71.5, 66.2, 32.9, 28.7, 27.4, 23.7, 18.3, 14.4; MS (FAB+) m/z: 268 [M + H]+; HRMS (FAB+) m/z: [M + H]+ Calcd for C14H22NO4 268.1549; Found 268.1542.

3.2.6. Tert-Butyl (2S,3S)-7-Hydroxy-3-Methoxymethoxy-3,7-Dimethyl-4,5-Dioxo-2-Pentyl-3,4,5,7-Tetrahydropyrano[2,3-c]pyrrole-6(2H)-Carboxylate (15)

To a stirred solution of 13 (1.7 mg, 0.0040 mmol) in CH2Cl2 (0.4 mL) was added Dess-Martin periodinane (3.9 mg, 0.0092 mmol) at room temperature. The reaction mixture was stirred for 5 h and then poured into a mixture of 5% aqueous Na2SO3, saturated aqueous NaHCO3 and H2O. The resulting mixture was extracted with Et2O and the combined organic layers were dried over Na2SO4 and concentrated in vacuo. The crude product was purified by column chromatography on silica gel (n-hexane/EtOAc 3:2) to afford 15 (1.6 mg, 94%, 6:5 inseparable mixture) as a colorless oil.
IR (neat/NaCl) 3404, 2931, 1768, 1636, 1317, 1151, 1027, 758 cm−1; 1H-NMR (400 MHz, CDCl3) δ 4.85 (dd, J = 3.0, 10.0 Hz, 1H × 5/11), 4.81 (dd, J = 3.0, 11.0 Hz, 1H × 6/11), 4.78 (d, J = 7.5 Hz, 1H), 4.73 (d, J = 7.5 Hz, 1H × 5/11), 4.68 (d, J = 7.5 Hz, 1H × 6/11), 3.36 (s, 3H × 5/11), 3.35 (s, 3H × 6/11), 1.88 (s, 3H × 6/11), 1.87 (s, 3H × 5/11), 1.80–1.60 (m, 2H), 1.57 (s, 9H), 1.50–1.42 (m, 2H), 1.37–1.30 (m, 4H), 1.35 (s, 3H × 6/11), 1.31 (s, 3H × 5/11), 0.92–0.88 (m, 3H); 13C-NMR (125 MHz, CDCl3) δ 186.0 (both isomers), 160.1 (both isomers), 150.9 (both isomers), 148.3 (both isomers), 103.1, 103.0, 92.95, 92.89, 90.4, 90.1, 85.9, 85.8, 84.4 (both isomers), 78.4, 78.3, 56.2, 56.1, 31.3 (both isomers), 28.1 (3C, both isomers), 27.52, 27.51, 25.4, 25.2, 23.5, 23.4, 22.4, 22.3, 15.6, 15.5, 13.9 (both isomers); MS (FAB+) m/z: 428 [M + H]+; HRMS (FAB+) m/z: [M + H]+ Calcd for C21H34NO8 428.2284; Found 428.2289.

3.2.7. (2S,3S)-3-Hydroxy-3-Methyl-7-Methylene-2-Pentyl-2,3,6,7-Tetrahydropyrano[2,3-c]pyrrole-4,5-Dione (16)

Compound 15 (1.7 mg, 0.0040 mmol) was dissolved in TFA (0.15 mL) and the resulting mixture was stirred for 6 h at room temperature. After concentration under vacuum, the crude product was used directly in the next step without further purification.
1H-NMR (400 MHz, CDCl3) δ 7.40 (br s, 1H), 5.32 (d, J = 2.4 Hz, 1H), 5.12 (d, J = 2.4 Hz, 1H), 4.36 (dd, J = 2.4, 9.6 Hz, 1H), 2.03–1.21 (m, 9H), 1.26 (s, 3H), 0.96–0.88 (m, 3H); 13C-NMR (100 MHz, CDCl3) δ 190.9, 164.4, 153.8, 135.7, 103.0, 97.7, 89.2, 72.1, 31.4, 27.6, 25.4, 22.5, 18.8, 14.0.

3.2.8. Proposed Structure of Paraphaeosphaeride C (17)

To a stirred solution of crude 16 (prepared above) in THF (1.0 mL) was added sodium triacetoxyborohydride (1.3 mg, 0.0061 mmol) at 0 °C. After stirring at the same temperature for 15 min, the mixture was allowed to warm to room temperature and stirring was continued for 1.5 h. As TLC analysis revealed the presence of unreacted 16, a second portion of sodium triacetoxyborohydride (4.3 mg, 0.020 mmol) was added at 0 °C and the mixture was stirred for an additional 15 min at room temperature. A third portion of sodium triacetoxyborohydride (6.0 mg, 0.028 mmol) was then added at 0 °C and the mixture was stirred for a further 1 h at room temperature. The reaction was then quenched with saturated aqueous NaHCO3 and extracted with EtOAc. The combined organic layers were washed with H2O and saturated aqueous NaCl, dried over Na2SO4 and concentrated in vacuo. The crude product was purified by column chromatography on silica gel (EtOAc) to afford 17 (0.6 mg, 56% over two steps) as a colorless oil.
[ α ] D 25 + 38.6 (c 0.08, MeOH); IR (neat/NaCl) 3348, 2954, 2927, 1685, 1638, 1455, 1363, 1262, 1025, 801 cm−1; 1H-NMR (500 MHz, CD3OD) δ 4.94 (d, J = 1.0 Hz, 1H), 4.85 (d, J = 1.0 Hz, 1H), 4.14 (br s, 1H), 4.10 (br d, J = 11.0 Hz, 1H), 1.90 (m, 1H), 1.66 (m, 1H), 1.59 (m, 1H), 1.41 (m, 1H), 1.34 (m, 4H), 1.31 (s, 3H), 0.91 (t, J = 7.0 Hz, 3H); 13C-NMR (125 MHz, CD3OD) δ 172.8, 160.5, 139.7, 107.8, 93.2, 87.8, 72.8, 67.5, 32.6, 29.2, 27.8, 23.6, 19.7, 14.3; MS (FAB+) m/z: 268 [M + H]+; HRMS (FAB+) m/z: [M + H]+ Calcd for C14H22NO4 268.1549; Found 268.1558.

Supplementary Materials

Copies of 1H and 13C-NMR spectra of all new compounds are available online.

Author Contributions

K.K. and R.K. performed the synthesis and K.K. managed the project under the direction of H.K.

Funding

This work was supported in part by a grant from the Dementia Drug Resource Development Center Project S1511016, the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.

Acknowledgments

We thank Shugeng Cao and Chun-Shun Li for their helpful discussions regarding NMR spectra.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Li, C.-S.; Ding, Y.; Yang, B.-J.; Miklossy, G.; Yin, H.-Q.; Walker, L.A.; Turksom, J.; Cao, S. A new metabolite with a unique 4-pyranone−γ-lactam−1,4-thiazine moiety from a Hawaiian-plant associated fungus. Org. Lett. 2015, 17, 3556–3559. [Google Scholar] [CrossRef] [PubMed]
  2. Maloney, K.N.; Hao, W.; Xu, J.; Gibbons, J.; Hucul, J.; Roll, D.; Brady, S.F.; Schroeder, F.C.; Clardy, J. Phaeosphaeride A, an inhibitor of STAT3-dependent signaling isolated from an endophytic fungus. Org. Lett. 2006, 8, 4067–4070. [Google Scholar] [CrossRef] [PubMed]
  3. Chatzimpaloglou, A.; Yavropoulou, M.P.; Rooij, K.E.; Biedermann, R.; Mueller, U.; Kaskel, S.; Sarli, V. Total synthesis and biological activity of the proposed structure of phaeosphaeride A. J. Org. Chem. 2012, 77, 9659–9667. [Google Scholar] [CrossRef] [PubMed]
  4. Chatzimpaloglou, A.; Kolosov, M.; Eckols, T.K.; Tweardy, D.J.; Sarli, V. Synthetic and biological studies of phaeosphaerides. J. Org. Chem. 2014, 79, 4043–4054. [Google Scholar] [CrossRef] [PubMed]
  5. Abzianidze, V.V.; Prokofieva, D.S.; Chisty, L.A.; Bolshakova, K.P.; Berestetskiy, A.O.; Panikorovskii, T.L.; Bogachenkov, A.S.; Holder, A.A. Synthesis of natural phaeosphaeride A derivatives and an in vitro evaluation of their anti-cancer potential. Bioorg. Med. Chem. Lett. 2015, 25, 5566–5569. [Google Scholar] [CrossRef] [PubMed]
  6. Abzianidze, V.V.; Bolshakova, K.P.; Prokofieva, D.S.; Berestetskiy, A.O.; Kuznetsova, V.A.; Trishin, Y.G. Synthesis of 7-(4-methylphenyl)thiomethyl and 7-morpholylmethyl derivatives of natural phaeosphaeride A and their cytotoxic activity. Mendeleev Commun. 2017, 27, 82–84. [Google Scholar] [CrossRef]
  7. Abzianidze, V.; Beltyukov, P.; Zakharenkova, S.; Moiseeva, N.; Mejia, J.; Holder, A.; Trishin, Y.; Berestetskiy, A.; Kuznetsov, V. Synthesis and biological evaluation of phaeosphaeride A derivatives as antitumor agents. Molecules 2018, 23, 3043. [Google Scholar] [CrossRef] [PubMed]
  8. Abzianidze, V.V.; Zakharenkova, S.A.; Moiseeva, N.I.; Beltyukov, P.P.; Polukeev, V.A.; Dubrovskii, Y.A.; Kuznetsov, V.A.; Trishin, Y.G.; Mejia, J.E.; Holder, A.A. Towards lead compounds as anti-cancer agents via new phaeosphaeride A derivatives. Bioorg. Med. Chem. Lett. 2019, 29, 59–61. [Google Scholar] [CrossRef] [PubMed]
  9. Kobayashi, K.; Okamoto, I.; Morita, N.; Kiyotani, T.; Tamura, O. Synthesis of the proposed structure of phaeosphaeride A. Org. Biomol. Chem. 2011, 9, 5825–5832. [Google Scholar] [CrossRef] [PubMed]
  10. Kobayashi, K.; Kobayashi, Y.; Nakamura, M.; Tamura, O.; Kogen, H. Establishment of relative and absolute configurations of phaeosphaeride A: Total synthesis of ent-phaeosphaeride A. J. Org. Chem. 2015, 80, 1243–1248. [Google Scholar] [CrossRef] [PubMed]
  11. Kobayashi, K.; Kunimura, R.; Tanaka, K., III; Tamura, O.; Kogen, H. Total synthesis of (–)-phaeosphaeride B by a biomimetic conversion from (–)-phaeosphaeride A. Tetrahedron 2017, 73, 2382–2388. [Google Scholar] [CrossRef]
  12. Krasovskiy, A.; Krasovskaya, V.; Knochel, P. Mixed Mg/Li amides of the type R2NMgCl·LiCl as highly efficient bases for the regioselective generation of functionalized aryl and heteroaryl magnesium compounds. Angew. Chem. Int. Ed. 2006, 45, 2958–2961. [Google Scholar] [CrossRef] [PubMed]
  13. Lin, W.; Baron, O.; Knochel, P. Highly functionalized benzene syntheses by directed mono or multiple magnesiations with TMPMgCl·LiCl. Org. Lett. 2006, 8, 5673–5676. [Google Scholar] [CrossRef] [PubMed]
  14. TMPMgCl·LiCl Was Purchased from Aldrich. Available online: https://www.sigmaaldrich.com/catalog/product/aldrich/703540?lang=ja&region=JP (accessed on 21 November 2019).
Sample Availability: Samples of the compounds are not available from the authors.
Figure 1. Structures of paraphaeosphaerides A–C (13) and phaeosphaerides A (4) and B (5).
Figure 1. Structures of paraphaeosphaerides A–C (13) and phaeosphaerides A (4) and B (5).
Molecules 24 04230 g001
Scheme 1. Our synthesis of phaeosphaerides A (4) and B (5) featuring a vinyl anion aldol reaction.
Scheme 1. Our synthesis of phaeosphaerides A (4) and B (5) featuring a vinyl anion aldol reaction.
Molecules 24 04230 sch001
Scheme 2. Unsuccessful formation of dihydropyran derivative 7 from aldehyde 6. (Reproduced with permission from [11].)
Scheme 2. Unsuccessful formation of dihydropyran derivative 7 from aldehyde 6. (Reproduced with permission from [11].)
Molecules 24 04230 sch002
Figure 2. Plausible Mg2+-stabilized transition state leading to 7.
Figure 2. Plausible Mg2+-stabilized transition state leading to 7.
Molecules 24 04230 g002
Scheme 3. Synthesis of bicyclic compound 11.
Scheme 3. Synthesis of bicyclic compound 11.
Molecules 24 04230 sch003
Scheme 4. Total synthesis of the proposed structure of paraphaeosphaeride C.
Scheme 4. Total synthesis of the proposed structure of paraphaeosphaeride C.
Molecules 24 04230 sch004
Figure 3. Structural characterization of synthetic compound 17 (* Upper values: PPPC (3) [1], Lower values: Synthetic 17; Reproduced with permission from [1]).
Figure 3. Structural characterization of synthetic compound 17 (* Upper values: PPPC (3) [1], Lower values: Synthetic 17; Reproduced with permission from [1]).
Molecules 24 04230 g003
Table 1. Vinyl anion aldol reaction of aldehyde 6.
Table 1. Vinyl anion aldol reaction of aldehyde 6.
EntryReagents (equiv)Temp (°C)Time (min)Result 1
1TMP (1.5), n-BuLi (1.5)−40106 (40%), 7 (21%), 8 (8%)
2TMP (3.0), n-BuLi (3.0)−40106 (7%), 7 (42%), 8 (9%)
3TMP (5.0), n-BuLi (5.0)−40107 (30%), 8 (5%)
4TMPMgCl·LiCl (3.0)−78207 (82%), 8 (9%)
1 Isolated yield.

Share and Cite

MDPI and ACS Style

Kobayashi, K.; Kunimura, R.; Kogen, H. Total Synthesis of the Proposed Structure of Paraphaeosphaeride C. Molecules 2019, 24, 4230. https://doi.org/10.3390/molecules24234230

AMA Style

Kobayashi K, Kunimura R, Kogen H. Total Synthesis of the Proposed Structure of Paraphaeosphaeride C. Molecules. 2019; 24(23):4230. https://doi.org/10.3390/molecules24234230

Chicago/Turabian Style

Kobayashi, Kenichi, Risako Kunimura, and Hiroshi Kogen. 2019. "Total Synthesis of the Proposed Structure of Paraphaeosphaeride C" Molecules 24, no. 23: 4230. https://doi.org/10.3390/molecules24234230

Article Metrics

Back to TopTop